Open AccessSubmicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery
Author(s) -
Raymond Fong,
Bruce E. Silverstein,
James Peace,
Jon I. Williams,
Jason L Vittitow
Publication year - 2018
Publication title -
journal of cataract and refractive surgery/journal of cataract and refractive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 142
eISSN - 1873-4502
pISSN - 0886-3350
DOI - 10.1016/j.jcrs.2018.06.056
Subject(s) - medicine , tolerability , intraocular pressure , visual acuity , cataract surgery , ophthalmology , randomized controlled trial , adverse effect , population , surgery , environmental health
To assess the safety and efficacy of a 0.38% submicron formulation of loteprednol etabonate (LE) gel for the treatment of postoperative inflammation and pain after cataract surgery.